Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

January 31, 2007

Date of Report (date of earliest event reported)

 


CUTERA, INC.

(Exact name of Registrant as specified in its charter)

 


 

Delaware   000-50644   77-0492262

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(I.R.S. Employer

Identification Number)

3240 Bayshore Blvd.

Brisbane, California 94005

(Address of principal executive offices)

(415) 657-5500

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02. Results of Operations and Financial Condition.

On January 31, 2007, we are issuing a press release and holding a conference call regarding our financial results for the fourth quarter and year ended December 31, 2006. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.  

Description

99.1   Press Release of Cutera, Inc. dated as of January 31, 2007.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

     CUTERA, INC.
Date: January 31, 2007   

            /s/ Kevin P. Connors

               Kevin P. Connors
               President and Chief Executive Officer
Press Release

EXHIBIT 99.1

LOGO

FOR IMMEDIATE RELEASE

CONTACTS:

Cutera, Inc.

Ron Santilli

Chief Financial Officer

415-657-5500

Investor Relations

John Mills

Integrated Corporate Relations, Inc.

310-954-1100

john.mills@icrinc.com

Cutera® Reports Fourth Quarter and Full Year 2006 Results

— Company Sets New Records for Quarterly Revenue and EPS —

BRISBANE, Calif., January 31, 2007 — Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and twelve months ended December 31, 2006. Key financial highlights are as follows:

Fourth quarter 2006, compared with the same quarter in 2005:

 

    Revenue increased by $6.5 million, or 27%, from $24.0 million to $30.5 million.

 

    GAAP diluted earnings per share, for the fourth quarter of 2006 was $0.50, compared with $0.41 in the fourth quarter of 2005. Non-GAAP(1) diluted earnings per share in the fourth quarter of 2006, which excluded stock-based compensation expenses, was $0.55.

 

    Cash generated by operations increased 93%, from $7.6 million to $14.6 million.

Full-year 2006, compared with full-year 2005:

 

    Revenue increased by $25.1 million, or 33%, from $75.6 million to $100.7 million.

 

    GAAP diluted earnings per share was $0.15. Non-GAAP(1) diluted earnings per share in 2006, which excluded patent litigation settlement and stock-based compensation expenses, was $1.18.

 

    Cash and marketable investments balance improved to $108.1 million in 2006.

“We are very pleased with our fourth quarter revenue growth in all of our geographic regions and the overall improvements in operations,” said Kevin Connors, President and Chief Executive Officer. “Our fourth quarter gross margin and operating margin improved to 73%


and 29%, respectively. We believe the strong revenue growth and improved leverage in our operating model, were primarily attributable to the strength of our multiple product offerings and investments in sales force expansion. As a result of these factors, we generated $14.6 million of cash flow from operations in the fourth quarter and ended the year with over $108 million of cash and marketable securities.”

Mr. Connors concluded, “2006 was an exciting year for Cutera - we maintained strong revenue growth, resolved our patent litigation and experienced improved financial leverage in our business model. We are very excited about the opportunities for our company in 2007, as we continue to focus on developing new products and applications and expanding our distribution channels. We expect these efforts will enable us to continue increasing our market share in the growing market for light-based aesthetic systems.”

Guidance:

Management expects revenue for the first quarter and full-year 2007, to be approximately $26 million and $126 million, respectively. This represents a 25% growth from the same periods in the prior year.

For the first quarter and full-year 2007, we expect GAAP diluted earnings per share to be $0.21 and $1.30, respectively. For the same periods, non-GAAP(1) diluted earnings per share, excluding stock-based compensation expenses, is expected to be $0.28 and $1.57, respectively.

Non-GAAP Presentation:

 

(1) Effective January 1, 2006, Cutera adopted Statement of Financial Accounting Standards (SFAS) No. 123(R), which required the Company to recognize compensation expense relating to share-based payment transactions in the Statement of Operations. In June 2006, the Company settled its patent litigation. To supplement the condensed consolidated financial information presented on a GAAP basis, management has provided non-GAAP net income and non-GAAP diluted income per share measures that exclude the impact of the litigation settlement and all stock-based compensation expenses, both net of income taxes. The Company believes that these non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of the company’s ongoing operating results and trends, compared with historical results. This presentation is also consistent with management’s internal use of the measure, which it uses to measure the performance of ongoing operating results, against prior periods and against our internally developed targets. A table reconciling the GAAP financial measures to the non-GAAP measures is included in the condensed consolidated financial information attached to this release.

Conference Call:

The conference call to discuss these results is scheduled to begin at 2:00 p.m. PST (5:00 p.m. EST) on January 31, 2007. The call will be broadcast live over the Internet hosted at the Investor Relations section of the Company’s website at www.cutera.com and will be archived online within one hour of its completion. In addition, you may call 877-704-5381 to listen to the live broadcast. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Chief Financial Officer.


A telephonic playback will be available from 5:00 p.m. PST (8:00 p.m. EST) on January 31, 2007, through 8:59 p.m. PST (11:59 p.m. EST) on February 14, 2007 by calling 888-203-1112. To access this playback, please enter pass code 8614033.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera’s opportunities in 2007, including the development of new products and applications and expansion of distribution channels, leading to increased market share, as well as Cutera’s financial guidance for the first quarter and full-year 2007, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera’s actual results to differ materially from the statements contained herein. Cutera’s fourth quarter and year ended December 31, 2006 financial performance, as discussed in this release, is preliminary and unaudited, and subject to adjustment. Estimates for the first quarter and fiscal year 2007 financial performance are subject to a number of assumptions regarding the future operation of our business. Further information on potential risk factors that could affect Cutera’s business and its financial results are detailed in its most recent 10-K and 10-Q as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.


CUTERA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

    

December 31,

2006

   

December 31,

2005

 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 11,800     $ 5,260  

Marketable investments

     96,285       86,736  

Accounts receivable, net

     9,601       6,478  

Inventory

     5,220       5,245  

Deferred tax asset

     5,792       3,027  

Other current assets

     2,702       3,728  
                

Total current assets

     131,400       110,474  

Property and equipment, net

     1,029       1,015  

Intangibles, net

     1,446       469  
                

Total assets

   $ 133,875     $ 111,958  
                

Liabilities and Stockholders' Equity

    

Current liabilities:

    

Accounts payable

   $ 2,212     $ 1,352  

Accrued liabilities

     13,675       9,131  

Deferred revenue

     3,514       1,673  
                

Total current liabilities

     19,401       12,156  

Deferred rent

     1,424       1,096  

Deferred revenue, net of current portion

     3,258       1,469  

Deferred tax liability

     60       60  
                

Total liabilities

     24,143       14,781  
                

Stockholders’ equity:

    

Common stock

     13       12  

Additional paid-in capital

     86,242       77,705  

Deferred stock-based compensation

     (331 )     (2,171 )

Retained earnings

     23,866       21,743  

Other comprehensive loss

     (58 )     (112 )
                

Total stockholders’ equity

     109,732       97,177  
                

Total liabilities and stockholders’ equity

   $ 133,875     $ 111,958  
                


CUTERA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

    

Three Months Ended

December 31,

  

Twelve Months Ended

December 31,

     2006    2005    2006     2005

Net revenue

   $ 30,481    $ 23,953    $ 100,692     $ 75,620

Cost of revenue

     8,349      6,149      29,859       19,792
                            

Gross profit

     22,132      17,804      70,833       55,828
                            

Operating expenses:

          

Sales and marketing

     7,865      7,167      32,890       25,021

Research and development

     1,935      1,421      6,473       5,353

General and administrative

     3,578      2,263      15,192       8,782

Litigation settlement

     —        —        18,935       —  
                            

Total operating expenses

     13,378      10,851      73,490       39,156
                            

Income (loss) from operations

     8,754      6,953      (2,657 )     16,672

Interest and other income, net

     981      683      3,596       2,034
                            

Income before income taxes

     9,735      7,636      939       18,706

Provision (benefit) for income taxes

     2,620      1,825      (1,184 )     4,905
                            

Net income

   $ 7,115    $ 5,811    $ 2,123     $ 13,801
                            

Net income per share:

          

Basic

   $ 0.56    $ 0.48    $ 0.17     $ 1.20
                            

Diluted

   $ 0.50    $ 0.41    $ 0.15     $ 1.00
                            

Weighted-average number of shares used in per share calculations:

          

Basic

     12,749      12,026      12,558       11,535
                            

Diluted

     14,346      14,291      14,278       13,864
                            


CUTERA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

    

Three Months Ended

December 31,

   

Twelve Months Ended

December 31,

 
     2006     2005     2006     2005  

Cash flows from operating activities:

        

Net income

   $ 7,115     $ 5,811     $ 2,123     $ 13,801  

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation and amortization

     233       185       869       689  

Change in allowance for doubtful accounts

     (80 )     (14 )     (143 )     (310 )

Provision for excess and obsolete inventory

     —         471       90       905  

Change in deferred tax asset/liability

     919       (1,347 )     (2,765 )     (735 )

Stock based compensation

     1,311       240       4,542       1,442  

Tax benefit from stock option exercises

     1,808       4,312       1,808       7,437  

Excess tax benefit related to share-based compensation expense

     (1,032 )     —         (1,032 )     —    

Changes in assets and liabilities:

        

Accounts receivable

     (397 )     (1,133 )     (2,980 )     475  

Inventory

     338       (716 )     (65 )     (3,146 )

Other current assets

     1,296       (1,215 )     1,026       (2,850 )

Accounts payable

     816       (273 )     860       157  

Accrued liabilities

     761       578       4,175       937  

Deferred rent

     82       112       328       448  

Deferred revenue

     1,404       559       3,630       1,138  
                                

Net cash provided by operating activities

     14,574       7,570       12,466       20,388  
                                

Cash flows from investing activities:

        

Acquisition of property and equipment

     (201 )     (125 )     (642 )     (539 )

Acquisition of intangibles

     —         —         (1,218 )     (165 )

Proceeds from sales of marketable investments

     11,219       30       23,522       18,324  

Proceeds from maturities of marketable investments

     22,746       15,575       99,439       49,948  

Purchase of short-term investments

     (42,649 )     (24,915 )     (132,456 )     (95,910 )
                                

Net cash used in investing activities

     (8,885 )     (9,435 )     (11,355 )     (28,342 )
                                

Cash flows from financing activities:

        

Proceeds from exercise of stock options and employee stock purchase plan

     2,021       2,397       4,397       6,144  

Excess tax benefit related to share-based compensation expense

     1,032       —         1,032       —    
                                

Net cash provided by financing activities

     3,053       2,397       5,429       6,144  
                                

Net increase (decrease) in cash and cash equivalents

     8,742       532       6,540       (1,810 )

Cash and cash equivalents at beginning of period

     3,058       4,728       5,260       7,070  
                                

Cash and cash equivalents at end of period

   $ 11,800     $ 5,260     $ 11,800     $ 5,260  
                                

Supplemental disclosure of cash flow information:

        

Cash paid (received) for income taxes, net

   $ (1,320 )   $ 212     $ (1,990 )   $ 1,837  

Change in deferred stock-based compensation, net of terminations

   $ (10 )   $ (6 )   $ (1,271 )   $ 1,387  


CUTERA, INC.

CONSOLIDATED REVENUE HIGHLIGHTS

(in thousands, except percentage data)

(unaudited)

 

     Three Months Ended December 31,     Twelve Months Ended December 31,  
     2006    2005    Change     2006    2005    Change  

Revenue By Geography:

                

United States

   $ 21,583    $ 18,274    +18 %   $ 70,299    $ 54,506    +29 %

International

     8,898      5,679    +57 %     30,393      21,114    +44 %
                                
   $ 30,481    $ 23,953    +27 %   $ 100,692    $ 75,620    +33 %
                                

Revenue By Product Category:

                

Products

   $ 25,974    $ 19,937    +30 %   $ 84,700    $ 63,349    +34 %

Product upgrades

     1,713      2,060    -17 %     6,006      6,630    -9 %

Service

     1,772      1,224    +45 %     5,890      3,881    +52 %

Titan refills

     1,022      732    +40 %     4,096      1,760    +133 %
                                
   $ 30,481    $ 23,953    +27 %   $ 100,692    $ 75,620    +33 %
                                


CUTERA, INC.

NON-GAAP RECONCILIATION OF NET INCOME AND NET INCOME PER SHARE

(in thousands, except per share data)

(unaudited)

 

     Three Months
Ended
12/31/2006
    Twelve Months
Ended
12/31/2006
 

GAAP net income

   $ 7,115     $ 2,123  
                

Non-GAAP adjustments to net income

    

Litigation settlement (a)

     —         18,935  

Income tax effect of litigation settlement (c)

     —         (7,199 )

Stock-based compensation (b)

     1,311       4,542  

Income tax effect of stock-based compensation (c)

     (534 )     (1,568 )
                

Total non-GAAP adjustments to net loss

     777       14,710  
                

Non-GAAP net income

   $ 7,892     $ 16,833  
                

GAAP diluted income per share

   $ 0.50     $ 0.15  

Non-GAAP adjustments to diluted income per share

    

Litigation settlement, net of income tax effect (a)(c)

     —         0.82  

Stock-based compensation, net of income tax effect (b)(c)

     0.05       0.21  
                

Non-GAAP diluted net income per share

   $ 0.55     $ 1.18  
                

Weighted-average shares used to compute both GAAP and non-GAAP diluted net income per share

     14,346       14,278  
                

(a) Includes litigation settlement expense recorded in June & September 2006.
(b) Includes all non-cash stock-based compensation charges recorded in accordance with SFAS 123(R).
(c) The income tax effect is based on the marginal tax impact of excluding the litigation settlement and stock based compensation expenses from the tax provision. It also includes the year-to-date true-up adjustment recorded in the quarter ended December 31, 2006.


CUTERA, INC.

NON-GAAP RECONCILIATION OF GUIDANCE NET INCOME AND NET INCOME PER SHARE

(in thousands, except per share data)

(unaudited)

 

     Three Months
Ended
March 31, 2007
    Year Ended
December 31, 2007
 

Guidance GAAP net income

   $ 3,100     $ 19,000  
                

Non-GAAP adjustments to net income

    

Stock-based compensation (a)

     1,400       5,800  

Income tax effect of stock-based compensation (b)

     (455 )     (1,900 )
                

Total non-GAAP adjustments to net income

     945       3,900  
                

Guidance non-GAAP net income

   $ 4,045     $ 22,900  
                

Guidance GAAP diluted net income per share

   $ 0.21     $ 1.30  

Non-GAAP adjustments to GAAP diluted net income per share

    

Stock-based compensation, net of income tax effect (a)(b)

     0.07       0.27  
                

Guidance non-GAAP diluted net income per share

   $ 0.28     $ 1.57  
                

Weighted-average shares used to compute GAAP and non-GAAP diluted net income per share

     14,475       14,650  
                

(a) Includes all non-cash stock-based compensation charges recorded in accordance with SFAS 123(R).
(b) The income tax effect is based on the marginal tax impact of excluding the stock based compensation expenses from the tax provision.